On the last working day of 2016, when the NEEQ listed companies in the total number of 10163, receiving the consent letter of “NEEQ Consent Letter: Number [2016]9934”，Guangdong New South Artemisia Annua Medicine Co., Ltd. (code: 870644) was successfully listed on NEEQ with Zhongyin senior partner, Gao Wei lawyers team ’s professional services. And this very day is also the 86th birthday of Mrs.Tu Youyou, the Nobel prize owner of our country.

The main business of New South is artemisinin antimalarial medicine, traditional Chinese medicine general medicine and all kinds of extract research and development, production and sales. The main products are artemisinin piperazine tablets, Chinese medicine generic drugs and various types of extract. ARTEQUICK is the artemisinin drug with independent intellectual property rights of artemisinin compound drugs, which is also one of the core products of Artemisia annua medicine. Many years ago, the president of Guangdong New South Group Co., Ltd (the controlling shareholder of Qinghao Pharmaceutical), Mr. Zhu Layi put forward the research and development and production of artemisinin compound research project. Artemisinin known for the Nobel Prize in the world, but the discovery of Tu Youyou applied to clinical and research and development of China with full intellectual property rights of artemisinin compound drugs, mainly with the pharmaceutical research and Artemisia Annua development team.

Occasional contains the inevitable. As Ms. Tu Youyou’s 86th birthday gift, the birth of China's capital market, the first "Artemisia annua mission, global health” responsibility of the NEEQ business. If the Nobel Prize ignited the common cause of China's Artemisia annua enthusiasm, then the capital market was injected into its inexhaustible endogenous motivation.